# Botulinum Toxin for the Treatment of Involuntary Movement Disorders

> **NCT00001208** · — · RECRUITING · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 2000 (estimated)

## Conditions studied

- Movement Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00001208
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 1989-10-26
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001208, "Botulinum Toxin for the Treatment of Involuntary Movement Disorders". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT00001208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*